rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency
Author:
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.1586/eci.11.5
Reference70 articles.
1. Treatment of type I and II hereditary angioedema with Rhucin®, a recombinant human C1 inhibitor
2. A biochemical abnormality in hereditary angioneurotic edema
3. Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: Functional and structural correlates
4. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor
5. Acquired angioedema
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Complement therapeutics are coming of age in rheumatology;Nature Reviews Rheumatology;2023-06-19
2. Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway;Journal of Medicinal Chemistry;2023-04-25
3. Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies;Hemato;2022-10-17
4. The Expression of Recombinant Human Serum Albumin in the Mammary Gland of Transgenic Mice;Pharmaceutical Fronts;2021-03
5. Expression of a recombinant anti-programed cell death 1 antibody in the mammary gland of transgenic mice;Preparative Biochemistry & Biotechnology;2020-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3